Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis.

[1]  N. Theodore,et al.  Report of two cases and review of the literature , 2006 .

[2]  A. Heiligenhaus,et al.  Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea. , 2005, Investigative ophthalmology & visual science.

[3]  H. Grossniklaus Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Rodriguez-Ares MT, * Tourino R, Lopez-Valladares MJ, Gude F. Cornea 2004;23:577–583 , 2004 .

[4]  Wei Li,et al.  How does amniotic membrane work? , 2004, The ocular surface.

[5]  C. Bouchard,et al.  Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. , 2004, The ocular surface.

[6]  H. Dua,et al.  The amniotic membrane in ophthalmology. , 2004, Survey of ophthalmology.

[7]  A. Heiligenhaus,et al.  Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation , 2003 .

[8]  A. Heiligenhaus,et al.  Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. , 2003, Experimental eye research.

[9]  E. Tedeschi-Reiner,et al.  Amniotic membrane transplantation for ocular surface reconstruction. , 2002, Collegium antropologicum.

[10]  T. Tervo,et al.  In Vivo Confocal Microscopy After Herpes Keratitis , 2002, Cornea.

[11]  S. Tseng,et al.  Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. , 2002, Ophthalmology.

[12]  P. Prabhasawat,et al.  Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation , 2001, The British journal of ophthalmology.

[13]  S. Tseng,et al.  Amniotic Membrane Transplantation for Ocular Surface Reconstruction , 2001, Bioscience reports.

[14]  A. Heiligenhaus,et al.  Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. , 2001, Investigative ophthalmology & visual science.

[15]  S. Tseng,et al.  Amniotic membrane transplantation for severe neurotrophic corneal ulcers , 2000, The British journal of ophthalmology.

[16]  D. H. Ma,et al.  Identification of Antiangiogenic and Antiinflammatory Proteins in Human Amniotic Membrane , 2000, Cornea.

[17]  N. Koizumi,et al.  Growth factor mRNA and protein in preserved human amniotic membrane , 2000 .

[18]  A. Heiligenhaus,et al.  Macrophage-depletion influences the course of murine HSV-1 keratitis. , 2000, Current eye research.

[19]  S. Tseng,et al.  Conjunctival epithelial cell differentiation on amniotic membrane. , 1999, Investigative ophthalmology & visual science.

[20]  E. Holland,et al.  Classification of herpes simplex virus keratitis. , 1999, Cornea.

[21]  M. Thiel,et al.  Improved impression cytology techniques for the immunopathological diagnosis of superficial viral infections , 1997, The British journal of ophthalmology.

[22]  R. Gentz,et al.  Cystatin E is a Novel Human Cysteine Proteinase Inhibitor with Structural Resemblance to Family 2 Cystatins* , 1997, The Journal of Biological Chemistry.

[23]  S. Tseng,et al.  Amniotic membrane transplantation for persistent epithelial defects with ulceration. , 1997, American journal of ophthalmology-glaucoma.

[24]  W. Jarosz,et al.  Antiviral nonspecific immunity of human placenta at term: possible role of endogenous tumor necrosis factors and interferons. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[25]  P. McDonnell,et al.  The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. , 1996, Ophthalmology.

[26]  W. Hauck,et al.  Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis , 1994 .

[27]  A. Heiligenhaus,et al.  Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. , 1993, Journal of immunology.

[28]  D. Pavan-Langston,et al.  Herpetic Keratitis: Persistence of Viral Particles Despite Topical and Systemic Antiviral Therapy: Report of Two Cases and Review of the Literature , 1993 .

[29]  L. Björck,et al.  Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus , 1990, Journal of virology.

[30]  Y. Gordon,et al.  Evaluation of Immunologlic Tests for the Detection of Ocular Herpes Simplex Virus , 1989 .

[31]  T. Liesegang Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. , 1989, Archives of ophthalmology.

[32]  Y. Gordon,et al.  Evaluation of immunologic tests for the detection of ocular herpes simplex virus. , 1989, Ophthalmology.

[33]  D. Pavan-Langston,et al.  Rapid detection of herpes simplex virus (HSV) antigen in human ocular infections. , 1988, Current eye research.

[34]  V. Turk,et al.  Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells. , 1985, Biochemical and biophysical research communications.

[35]  Angela Ready Perforations. , 1938, California and western medicine.